Making Cancer Less Deadly Through Widely Accessible Early Detection
DELFI unleashes the power of machine learning and next-generation liquid biopsies to detect cancer in a whole new way.
Longer, Cancer-Free Lives
DELFI’s technology was developed to help people live longer, healthier, cancer-free lives by detecting cancer early—when it’s asymptomatic but easier to cure.
Widely Available Screening
Effective cancer screening requires a test accessible to everyone who needs one. DELFI’s machine learning tools work with commonly used lab methods and instruments, making early-stage cancer screening affordable and feasible for large populations.
High-Performance Technology
DELFI’s machine learning system analyzes far more molecular data than conventional methods, deriving deeper clinical insights.
Serving Unmet Medical Needs
Millions of high-risk individuals are not getting screened for cancer due to access and cost. A blood-based cancer screening test is easy to incorporate into routine clinical practice, with the potential to impact populations around the world.
